Search results for: diabetes

Bariatric Surgery May Help Obese Patients with Gout, Diabetes

Kathy Holliman | August 1, 2014

Researchers found patients with morbid obesity, gout and diabetes achieved target serum urate concentrations post-bariatric surgery

Prednisone or Methotrexate for Pulmonary Sarcoidosis?

Deborah Levenson | December 11, 2025

The recently released PREDMETH study results indicate that methotrexate can be considered a real alternative to prednisone for patients with pulmonary sarcoidosis.

Rethinking Lupus Nephritis: Are Current Approaches & Guidelines off Target?

Mithu Maheswaranathan, MD | December 9, 2025

A rheumatologist & lupus expert reviews lupus nephritis treatment, questioning proteinuria cutoffs & ACR guidelines, advocating for newer therapies & end-of-treatment biopsies.

Lupus Nephritis: A Serious Manifestation of Systemic Lupus Erythematosus

Graciela S. Alarcón, MD, MPH, MACR | December 6, 2025

This review highlights some of the many abstracts on lupus nephritis research presented at ACR Convergence 2025. They demonstrate advances made on early recognition of the condition, as well as offering some hope in terms of achieving better outcomes.

Peripheral Neuropathy Common Among Patients with Sjögren’s Disease

Vanessa Caceres | November 18, 2025

At this ACR Convergence session, experts discussed the peripheral nervous system involvement with Sjögren’s disease that can have several manifestations.

Secrets & Pearls of Rheumatology at ACR Convergence 2025

Mithu Maheswaranathan, MD | November 12, 2025

Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.

New Rheumatoid Arthritis Risk Stratification Criteria Released

Ruth Jessen Hickman, MD | November 10, 2025

New EULAR/ACR criteria help stratify RA risk in patients with arthralgia. Learn how these criteria guide earlier interventions & improve trial rigor.

The Microbiome’s Impact on Rheumatoid Arthritis & Drug Response

Ruth Jessen Hickman, MD | November 7, 2025

The gut microbiome may trigger RA & predict methotrexate response. ACR Convergence 2025 experts discuss pathogenesis & drug efficacy.

Let’s Discuss Part 2: More Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR | October 28, 2025

The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on cutaneous manifestations of rheumatic diseases, gout, macrophage activation syndrome and vasculitis.

Gout & Cardiometabolic Co-Morbidities

Jason Liebowitz, MD, FACR | October 28, 2025

ACR Convergence 2025 experts explore gout’s deep ties to MetS, insulin resistance and cardiovascular mortality, weighing new data on colchicine, febuxostat and SGLT2 inhibitors.